Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
US5536749A · kind A · utility
5Cited by
23References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 13, 1994 |
| Grant date | Jul 16, 1996 |
| Priority date | — |
| Expiry date | Oct 13, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method for attenuating sympathetic nervous system hyperactivity or onset of migraine in a patient in need of such treatment, by the sublingual, buccal or intranasal administration to such patient of a therapeutically effective amount of a compound of the formula ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.